These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 23785020)

  • 1. Growth hormone (GH) activity is associated with increased serum oestradiol and reduced anti-Müllerian hormone in healthy male volunteers treated with GH and a GH antagonist.
    Andreassen M; Frystyk J; Faber J; Kristensen LØ; Juul A
    Andrology; 2013 Jul; 1(4):595-601. PubMed ID: 23785020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of growth hormone replacement therapy on IGF-related parameters and on the pituitary-gonadal axis in GH-deficient males. A double-blind, placebo-controlled crossover study.
    Juul A; Andersson AM; Pedersen SA; Jørgensen JO; Christiansen JS; Groome NP; Skakkebaek NE
    Horm Res; 1998; 49(6):269-78. PubMed ID: 9623518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GH activity and markers of inflammation: a crossover study in healthy volunteers treated with GH and a GH receptor antagonist.
    Andreassen M; Frystyk J; Faber J; Kristensen LØ
    Eur J Endocrinol; 2012 May; 166(5):811-9. PubMed ID: 22408123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Longitudinal Study of Growth, Sex Steroids, and IGF-1 in Boys With Physiological Gynecomastia.
    Mieritz MG; Rakêt LL; Hagen CP; Nielsen JE; Talman ML; Petersen JH; Sommer SH; Main KM; Jørgensen N; Juul A
    J Clin Endocrinol Metab; 2015 Oct; 100(10):3752-9. PubMed ID: 26287961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness.
    van den Berghe G; Weekers F; Baxter RC; Wouters P; Iranmanesh A; Bouillon R; Veldhuis JD
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3217-26. PubMed ID: 11443192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testicular size development and reproductive hormones in boys and adult males with Noonan syndrome: a longitudinal study.
    Ankarberg-Lindgren C; Westphal O; Dahlgren J
    Eur J Endocrinol; 2011 Jul; 165(1):137-44. PubMed ID: 21551165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testis function in prepubertal boys and young men born small for gestational age.
    Boonstra VH; Weber RF; de Jong FH; Hokken-Koelega AC
    Horm Res; 2008; 70(6):357-63. PubMed ID: 18953173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discontinuation of estrogen replacement therapy in GH-treated hypopituitary women alters androgen status and IGF-I.
    Christiansen JJ; Fisker S; Gravholt CH; Bennett P; Svenstrup B; Andersen M; Feldt-Rasmussen U; Christiansen JS; Jørgensen JO
    Eur J Endocrinol; 2005 May; 152(5):719-26. PubMed ID: 15879357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Male patients with terminal renal failure exhibit low serum levels of antimüllerian hormone.
    Eckersten D; Giwercman A; Christensson A
    Asian J Androl; 2015; 17(1):149-53. PubMed ID: 25130586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian follicular development and the follicular fluid hormones and growth factors in normal women of advanced reproductive age.
    Klein NA; Battaglia DE; Miller PB; Branigan EF; Giudice LC; Soules MR
    J Clin Endocrinol Metab; 1996 May; 81(5):1946-51. PubMed ID: 8626862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Menstrual Pattern, Reproductive Hormones, and Transabdominal 3D Ultrasound in 317 Adolescent Girls.
    Assens M; Dyre L; Henriksen LS; Brocks V; Sundberg K; Jensen LN; Pedersen AT; Main KM
    J Clin Endocrinol Metab; 2020 Sep; 105(9):. PubMed ID: 32506132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor activity of the growth hormone receptor antagonist pegvisomant against human meningiomas in nude mice.
    McCutcheon IE; Flyvbjerg A; Hill H; Li J; Bennett WF; Scarlett JA; Friend KE
    J Neurosurg; 2001 Mar; 94(3):487-92. PubMed ID: 11235955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of human recombinant luteinizing hormone and follicle-stimulating hormone in patients with acquired hypogonadotropic hypogonadism: study of Sertoli and Leydig cell secretions and interactions.
    Young J; Couzinet B; Chanson P; Brailly S; Loumaye E; Schaison G
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3239-44. PubMed ID: 10999815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor-1 is associated with regulation of the luteinizing hormone production in men receiving androgen deprivation therapy with gonadotropin-releasing hormone analogues for localized prostate cancer.
    Hara N; Takizawa I; Isahaya E; Nishiyama T; Hoshii T; Ishizaki F; Takahashi K
    Urol Oncol; 2012 Sep; 30(5):596-601. PubMed ID: 21458314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine regulation of growth hormone and androgen axes by selective estrogen receptor modulators in healthy men.
    Birzniece V; Sata A; Sutanto S; Ho KK
    J Clin Endocrinol Metab; 2010 Dec; 95(12):5443-8. PubMed ID: 20843951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statistically significant changes of antimüllerian hormone and inhibin levels during the physiologic menstrual cycle in reproductive age women.
    Wunder DM; Bersinger NA; Yared M; Kretschmer R; Birkhäuser MH
    Fertil Steril; 2008 Apr; 89(4):927-33. PubMed ID: 17603052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum inhibin B in healthy pubertal and adolescent boys: relation to age, stage of puberty, and follicle-stimulating hormone, luteinizing hormone, testosterone, and estradiol levels.
    Andersson AM; Juul A; Petersen JH; Müller J; Groome NP; Skakkebaek NE
    J Clin Endocrinol Metab; 1997 Dec; 82(12):3976-81. PubMed ID: 9398699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of a GH receptor antagonist (GHRA) to explore the relationship between GH and IGF-I in adults with severe GH deficiency (GHD).
    Berg CA; Pokrajac A; Bidlingmaier M; Strasburger CJ; Shalet SM; Trainer PJ
    Clin Endocrinol (Oxf); 2009 Mar; 70(3):439-45. PubMed ID: 19067728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term modulation of the androgen milieu alters pulsatile, but not exercise- or growth hormone (GH)-releasing hormone-stimulated GH secretion in healthy men: impact of gonadal steroid and GH secretory changes on metabolic outcomes.
    Fryburg DA; Weltman A; Jahn LA; Weltman JY; Samojlik E; Hintz RL; Veldhuis JD
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3710-9. PubMed ID: 9360530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age and markers of Leydig cell function, but not of Sertoli cell function predict the success of sperm retrieval in adolescents and adults with Klinefelter's syndrome.
    Rohayem J; Fricke R; Czeloth K; Mallidis C; Wistuba J; Krallmann C; Zitzmann M; Kliesch S
    Andrology; 2015 Sep; 3(5):868-75. PubMed ID: 26235799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.